NCT06962826View on ClinicalTrials.gov

A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With Food

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

June 26, 2025

Study Completion Date

September 12, 2025

Conditions
Healthy
Interventions
DRUG

Empagliflozin

Empagliflozin

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06962826 - A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With Food | Biotech Hunter | Biotech Hunter